Comprehensive Genomic Profiling Reveals the Mutational Spectrum and Clinical Significance of BRCA1/2 and Other Cancer-Susceptibility Genes in Breast Cancer Patients from Southern Tunisia. [PDF]
Ammous-Boukhris N +11 more
europepmc +1 more source
Genes Involved in the Cisplatin Response of BRCA2 Cancers
Breast and ovarian cancers are two of the most prevalent types of cancer in women and kill over 55,000 people annually in the US alone. A number of these cases are deficient in BRCA1 or 2, tumor suppressor genes involved in DNA repair.
Rose, Juliana Mary
core +1 more source
Breast-Ovarian Hereditary Cancer Syndrome: Beyond <i>BRCA1</i> and <i>BRCA2</i>. [PDF]
Imyanitov E, Sokolenko A.
europepmc +1 more source
STN1 upregulation promotes PARPi resistance in BRCA2-deficient cancer cells via replication fork protection and suppression of ssDNA gap formation. [PDF]
Laghari ZA +4 more
europepmc +1 more source
Pathogenic germline variants in BRCA1/2 are associated with a decreased number of hypomethylated rDNA copies. [PDF]
Kießling S +5 more
europepmc +1 more source
Double heterozygous germline pathogenic variants in patients referred to a tertiary cancer genetics clinic in Singapore. [PDF]
Wong RSJ +6 more
europepmc +1 more source
El descubrimiento de los genes BRCA1 y BRCA2 ha llevado a la introducción de pruebas genéticas cada vez más sofisticadas para medir el riesgo de cáncer de mama de origen hereditario, entre otras cosas.
Adriana A Rodríguez, Steven A Narod
core
Comparative phylogenetic analysis of breast cancer susceptibility genes reveals evolutionary conservation supporting diagnostic barcode design. [PDF]
Rehman SU.
europepmc +1 more source
A Multiplex RT-QPCR Assay of ONECUT2, EZH2, and BRCA2 for the Detection of Clinically Significant Prostate Cancer in Needle Biopsies. [PDF]
Inoue Y +17 more
europepmc +1 more source
<i>BRCA1</i> Gene as a Potential Marker for Lung Cancer Therapy. [PDF]
Tsyganov MM +3 more
europepmc +1 more source

